Showing results (411-420 of 443) with videos related to
Sort By:
Pageof 45
Cancer Biotherapy & Radiopharmaceuticals|August 20, 2019
In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and PotencyRose M Berman, Olivia J Kelada, Nicholas T Gutsche, et al.Nature Communications|September 22, 2023
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumoursDan Li, Ruixue Wang, Tianyuzhou Liang, et al.Journal for Immunotherapy of Cancer|April 9, 2021
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular CarcinomaLuan Sun, Fang Gao, Zhanhui Gao, et al.Molecular Pharmaceutics|May 9, 2015
Glypican-3 targeted human heavy chain antibody as a drug carrier for hepatocellular carcinoma therapyHirofumi Hanaoka, Tadanobu Nagaya, Kazuhide Sato, et al.Molecular Cancer Therapeutics|November 2, 2021
Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in MiceXin Chen, Yanmin Chen, Rong Liang, et al.Hepatology (Baltimore, Md.)|April 10, 2019
A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in MiceNa Li, Liwen Wei, Xiaoyu Liu, et al.Nature Communications|April 8, 2023
The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancerNan Li, Alex Quan, Dan Li, et al.Journal of Neuro-Oncology|December 3, 2003
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumorsJohn H Sampson, Gamal Akabani, Gary E Archer, et al.Biorxiv : the Preprint Server for Biology|April 17, 2026
Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinomaMan Hsin Hung, Qin Li, Limin Wang, et al.Journal for Immunotherapy of Cancer|January 11, 2023
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastomaMing Sun, Yingying Cao, Reona Okada, et al.Pageof 45